Undecimal Bio launches with $18 million oversubscribed seed financing to address ‘liver trap’ in siRNA therapeutic delivery

Undecimal Bio, a platform biotechnology company advancing targeted delivery of siRNA therapeutics, today announced an oversubscribed $18 million USD seed financing.

Read Original Copy